Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIF - Post by User

IMV Inc > Thoughts on SP creeping up anyone?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(5)
•••
Comment by alexmed95on Sep 15, 2020 10:48am
193 Views
Post# 31559631

RE:Thoughts on SP creeping up anyone?

RE:Thoughts on SP creeping up anyone?
Thought the same but summer "ending September 21th" as the CEO said to QM45 if I remember correctly. Must be the anticipation of pre-clinical result publication in a reputable journal as well as the start of phase I.  
 
That's my bet. 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities